The Biology Behind the Diagnosis
At a Glance
Chylomicron retention disease is caused by changes in both copies of SAR1B, which prevent intestinal cells from properly releasing dietary fat into the bloodstream. Diagnosis combines lipid testing, genetic evaluation, and sometimes endoscopy with biopsy.
To understand Chylomicron Retention Disease (CMRD), it helps to think of your child’s intestinal cells as a shipping warehouse. In a healthy body, these cells take in dietary fat, package it into transport vehicles called chylomicrons, and ship them out into the bloodstream. In a child with CMRD, the “shipping door” is broken because of a mutation in the SAR1B gene [1][2].
The Biological “Shipping Error”
The SAR1B gene provides instructions for a protein that acts like a manager at the warehouse exit. Its job is to help load large fat packages onto the “conveyor belt” (known as the COPII pathway) so they can leave the cell and enter the blood [2].
When the SAR1B gene is mutated, it impairs the intestinal assembly and/or secretion of chylomicrons. The fat is taken into the intestinal cells (enterocytes), but its secretion is severely impaired. Because it can’t exit normally, the fat gets retained inside the cells [1].
How CMRD Differs From Its “Look-Alikes”
CMRD is often compared to two other rare genetic conditions: Abetalipoproteinemia (ABL) and Homozygous Familial Hypobetalipoproteinemia (HFHBL). While all three cause severe fat malabsorption, there are key differences in how they appear on advanced blood tests:
| Feature | CMRD (Anderson Disease) | Abetalipoproteinemia (ABL) | HFHBL |
|---|---|---|---|
| Genetic Cause | SAR1B gene mutation [1] | MTTP gene mutation [3] | APOB gene mutation [4] |
| Fasting Triglycerides | Often Normal [5] | Extremely Low [4] | Extremely Low [4] |
| ApoB-48 (a key transport protein) | Typically absent or markedly reduced in plasma after a fat meal [1] | Absent [4] | Can vary, often very low or absent [4] |
| ApoB-100 | Can vary (low but often present) [1] | Absent [4] | Can vary, often very low or absent [4] |
A hallmark of CMRD is that fasting triglycerides—the level of fat in the blood after not eating—are often normal [5]. This is because the liver can still export its own fat; only the intestinal export of dietary fat is broken [1].
The Diagnostic Work-Up
Because the symptoms of CMRD overlap with common conditions, doctors typically use a combination of tests. The work-up is individualized for each child and may include:
- Ruling Out the Common: Doctors often first test for Celiac disease, a much more common cause of malabsorption [6].
- Lipid Profile: Blood tests may show very low total cholesterol, low LDL (“bad” cholesterol), and low HDL (“good” cholesterol) [7][8].
- Genetic Testing: The confirmation often comes from a genetic test that identifies biallelic mutations in the SAR1B gene [1][9]. A result showing a “Variant of Uncertain Significance” (VUS) does not establish CMRD on its own. Genetic counseling is highly recommended to help interpret results and discuss testing for relatives.
- Endoscopy and Biopsy (If needed): While not strictly required for every child (especially if genetic tests are conclusive), an endoscopy may be performed. In some CMRD cases, the lining of the intestine looks whitish because of the trapped fat. A tissue biopsy might reveal lipid-laden enterocytes (intestinal cells physically stuffed full of fat droplets) [9][10][11].
Common questions in this guide
What causes chylomicron retention disease?
Why can fasting triglycerides be normal in CMRD?
How is chylomicron retention disease diagnosed?
Does a variant of uncertain significance confirm CMRD?
How is CMRD different from abetalipoproteinemia and familial hypobetalipoproteinemia?
Get notified when new evidence is published on Chylomicron retention disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Chylomicron retention disease: genetics, biochemistry, and clinical spectrum.
Levy E, Poinsot P, Spahis S
Current opinion in lipidology 2019; (30(2)):134-139 doi:10.1097/MOL.0000000000000578.
PMID: 30640893 - 2
Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly.
Melville DB, Studer S, Schekman R
The Journal of biological chemistry 2020; (295(25)):8401-8412 doi:10.1074/jbc.RA120.012964.
PMID: 32358066 - 3
Complex genetic architecture in severe hypobetalipoproteinemia.
Wang LR, McIntyre AD, Hegele RA
Lipids in health and disease 2018; (17(1)):48 doi:10.1186/s12944-018-0680-1.
PMID: 29540175 - 4
Low cholesterol states: clinical implications and management.
Gill PK, Hegele RA
Expert review of endocrinology & metabolism 2023; (18(3)):241-253 doi:10.1080/17446651.2023.2204932.
PMID: 37089071 - 5
Chylomicron retention disease: A rare cause of chronic diarrhea.
Ben Ameur S, Aloulou H, Jlidi N, et al.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2016; (23(7)):735-7.
PMID: 27266643 - 6
European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective.
Lenti MV, Hammer HF, Tacheci I, et al.
United European gastroenterology journal 2025; (13(5)):773-797 doi:10.1002/ueg2.70011.
PMID: 40088199 - 7
Guidance for the diagnosis and treatment of hypolipidemia disorders.
Bredefeld C, Hussain MM, Averna M, et al.
Journal of clinical lipidology 2022; (16(6)):797-812 doi:10.1016/j.jacl.2022.08.009.
PMID: 36243606 - 8
Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
Blanco-Vaca F, Martin-Campos JM, Beteta-Vicente Á, et al.
Atherosclerosis 2019; (283()):52-60 doi:10.1016/j.atherosclerosis.2019.01.036.
PMID: 30782561 - 9
[Chylomicron retention disease caused by SAR1B gene variations in 2 cases and literatures review].
Zhang YQ, Wu LT, Cheng Y, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2024; (62(6)):565-570 doi:10.3760/cma.j.cn112140-20240301-00138.
PMID: 38763880 - 10
Chylomicron retention disease caused by a new pathogenic variant in sar1b protein: a rare case report from Syria.
Doya LJ, Mohammad L, Omran R, et al.
BMC pediatrics 2021; (21(1)):449 doi:10.1186/s12887-021-02897-5.
PMID: 34629076 - 11
Novel mutations of SAR1B gene in four children with chylomicron retention disease.
Simone ML, Rabacchi C, Kuloglu Z, et al.
Journal of clinical lipidology 2019; (13(4)):554-562 doi:10.1016/j.jacl.2019.05.013.
PMID: 31253576
This page explains the biology and diagnostic testing of chylomicron retention disease for educational purposes. A pediatric gastroenterologist, geneticist, or other healthcare professional should interpret your child's results and advise on care.